Targeting BRD4 mitigates hepatocellular lipotoxicity by suppressing the NLRP3 inflammasome activation and GSDMD-mediated hepatocyte pyroptosis.

MLA

Chen, Fangyuan, et al. “Targeting BRD4 Mitigates Hepatocellular Lipotoxicity by Suppressing the NLRP3 Inflammasome Activation and GSDMD-Mediated Hepatocyte Pyroptosis.” Cellular & Molecular Life Sciences, vol. 81, no. 1, July 2024, pp. 1–19. EBSCOhost, https://doi.org/10.1007/s00018-024-05328-7.

APA

Chen, F., Li, S., Liu, M., Qian, C., Shang, Z., Song, X., Jiang, W., & Tu, C. (2024). Targeting BRD4 mitigates hepatocellular lipotoxicity by suppressing the NLRP3 inflammasome activation and GSDMD-mediated hepatocyte pyroptosis. Cellular & Molecular Life Sciences, 81(1), 1–19. https://doi.org/10.1007/s00018-024-05328-7

Chicago

Chen, Fangyuan, Shuyu Li, Min Liu, Cheng Qian, Zhiyin Shang, Xu Song, Wei Jiang, and Chuantao Tu. 2024. “Targeting BRD4 Mitigates Hepatocellular Lipotoxicity by Suppressing the NLRP3 Inflammasome Activation and GSDMD-Mediated Hepatocyte Pyroptosis.” Cellular & Molecular Life Sciences 81 (1): 1–19. doi:10.1007/s00018-024-05328-7.